nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—PTGS1—Ifosfamide—testicular cancer	0.102	0.123	CbGbCtD
Zafirlukast—ABCG2—Dactinomycin—testicular cancer	0.0933	0.113	CbGbCtD
Zafirlukast—ABCG2—Carboplatin—testicular cancer	0.0627	0.0758	CbGbCtD
Zafirlukast—CYP2C8—Ifosfamide—testicular cancer	0.0587	0.071	CbGbCtD
Zafirlukast—ABCG2—Cisplatin—testicular cancer	0.0536	0.0648	CbGbCtD
Zafirlukast—ABCG2—Etoposide—testicular cancer	0.0526	0.0637	CbGbCtD
Zafirlukast—CYP2C19—Ifosfamide—testicular cancer	0.0492	0.0595	CbGbCtD
Zafirlukast—PTGS1—Etoposide—testicular cancer	0.0486	0.0588	CbGbCtD
Zafirlukast—CYP2C9—Ifosfamide—testicular cancer	0.0409	0.0495	CbGbCtD
Zafirlukast—CYP2E1—Etoposide—testicular cancer	0.0375	0.0454	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—testicular cancer	0.0359	0.0434	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—testicular cancer	0.0348	0.0421	CbGbCtD
Zafirlukast—CYP2C8—Etoposide—testicular cancer	0.028	0.0339	CbGbCtD
Zafirlukast—CYP3A4—Ifosfamide—testicular cancer	0.0238	0.0288	CbGbCtD
Zafirlukast—CYP1A2—Etoposide—testicular cancer	0.0217	0.0263	CbGbCtD
Zafirlukast—CYP2C9—Cisplatin—testicular cancer	0.0199	0.0241	CbGbCtD
Zafirlukast—CYP2D6—Vinblastine—testicular cancer	0.0198	0.024	CbGbCtD
Zafirlukast—CYP3A4—Vinblastine—testicular cancer	0.0126	0.0153	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—testicular cancer	0.0122	0.0148	CbGbCtD
Zafirlukast—CYP3A4—Etoposide—testicular cancer	0.0114	0.0138	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—testicular cancer	0.00775	0.00938	CbGbCtD
Zafirlukast—Oedema—Bleomycin—testicular cancer	0.000547	0.00315	CcSEcCtD
Zafirlukast—Neuropathy—Epirubicin—testicular cancer	0.000544	0.00314	CcSEcCtD
Zafirlukast—Infection—Bleomycin—testicular cancer	0.000543	0.00313	CcSEcCtD
Zafirlukast—Agranulocytosis—Etoposide—testicular cancer	0.00054	0.00311	CcSEcCtD
Zafirlukast—Thrombocytopenia—Bleomycin—testicular cancer	0.000535	0.00309	CcSEcCtD
Zafirlukast—Feeling abnormal—Vinblastine—testicular cancer	0.000534	0.00308	CcSEcCtD
Zafirlukast—Myalgia—Dactinomycin—testicular cancer	0.000532	0.00307	CcSEcCtD
Zafirlukast—Ill-defined disorder—Ifosfamide—testicular cancer	0.000531	0.00306	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vinblastine—testicular cancer	0.000529	0.00305	CcSEcCtD
Zafirlukast—Discomfort—Dactinomycin—testicular cancer	0.000526	0.00303	CcSEcCtD
Zafirlukast—Angioedema—Ifosfamide—testicular cancer	0.000523	0.00302	CcSEcCtD
Zafirlukast—Influenza like illness—Doxorubicin—testicular cancer	0.000521	0.003	CcSEcCtD
Zafirlukast—Hypersensitivity—Chlorambucil—testicular cancer	0.000521	0.003	CcSEcCtD
Zafirlukast—Hypoaesthesia—Etoposide—testicular cancer	0.000517	0.00298	CcSEcCtD
Zafirlukast—Malaise—Ifosfamide—testicular cancer	0.000516	0.00298	CcSEcCtD
Zafirlukast—Abdominal pain—Vinblastine—testicular cancer	0.000512	0.00295	CcSEcCtD
Zafirlukast—Oedema—Dactinomycin—testicular cancer	0.00051	0.00294	CcSEcCtD
Zafirlukast—Asthenia—Chlorambucil—testicular cancer	0.000507	0.00292	CcSEcCtD
Zafirlukast—Infection—Dactinomycin—testicular cancer	0.000507	0.00292	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—testicular cancer	0.000504	0.0029	CcSEcCtD
Zafirlukast—Hepatic failure—Methotrexate—testicular cancer	0.000501	0.00289	CcSEcCtD
Zafirlukast—Pruritus—Chlorambucil—testicular cancer	0.0005	0.00288	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dactinomycin—testicular cancer	0.000499	0.00288	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000498	0.00287	CcSEcCtD
Zafirlukast—Arthralgia—Ifosfamide—testicular cancer	0.000487	0.00281	CcSEcCtD
Zafirlukast—Myalgia—Ifosfamide—testicular cancer	0.000487	0.00281	CcSEcCtD
Zafirlukast—Diarrhoea—Chlorambucil—testicular cancer	0.000483	0.00279	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Epirubicin—testicular cancer	0.000482	0.00278	CcSEcCtD
Zafirlukast—Discomfort—Ifosfamide—testicular cancer	0.000482	0.00278	CcSEcCtD
Zafirlukast—Hypersensitivity—Vinblastine—testicular cancer	0.000477	0.00275	CcSEcCtD
Zafirlukast—Hepatic failure—Epirubicin—testicular cancer	0.000468	0.0027	CcSEcCtD
Zafirlukast—Pain—Bleomycin—testicular cancer	0.000468	0.0027	CcSEcCtD
Zafirlukast—Oedema—Ifosfamide—testicular cancer	0.000467	0.00269	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000465	0.00268	CcSEcCtD
Zafirlukast—Asthenia—Vinblastine—testicular cancer	0.000465	0.00268	CcSEcCtD
Zafirlukast—Infection—Ifosfamide—testicular cancer	0.000464	0.00268	CcSEcCtD
Zafirlukast—Ill-defined disorder—Cisplatin—testicular cancer	0.000458	0.00264	CcSEcCtD
Zafirlukast—Thrombocytopenia—Ifosfamide—testicular cancer	0.000458	0.00264	CcSEcCtD
Zafirlukast—Feeling abnormal—Bleomycin—testicular cancer	0.000451	0.0026	CcSEcCtD
Zafirlukast—Vomiting—Chlorambucil—testicular cancer	0.000449	0.00259	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000446	0.00257	CcSEcCtD
Zafirlukast—Malaise—Cisplatin—testicular cancer	0.000445	0.00257	CcSEcCtD
Zafirlukast—Diarrhoea—Vinblastine—testicular cancer	0.000443	0.00255	CcSEcCtD
Zafirlukast—Dermatitis bullous—Epirubicin—testicular cancer	0.00044	0.00254	CcSEcCtD
Zafirlukast—Fatigue—Dactinomycin—testicular cancer	0.00044	0.00254	CcSEcCtD
Zafirlukast—Back pain—Etoposide—testicular cancer	0.000437	0.00252	CcSEcCtD
Zafirlukast—Pain—Dactinomycin—testicular cancer	0.000436	0.00251	CcSEcCtD
Zafirlukast—Urticaria—Bleomycin—testicular cancer	0.000434	0.0025	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—testicular cancer	0.000433	0.0025	CcSEcCtD
Zafirlukast—Body temperature increased—Bleomycin—testicular cancer	0.000432	0.00249	CcSEcCtD
Zafirlukast—Dizziness—Vinblastine—testicular cancer	0.000428	0.00247	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000426	0.00246	CcSEcCtD
Zafirlukast—Myalgia—Cisplatin—testicular cancer	0.00042	0.00242	CcSEcCtD
Zafirlukast—Feeling abnormal—Dactinomycin—testicular cancer	0.00042	0.00242	CcSEcCtD
Zafirlukast—Nausea—Chlorambucil—testicular cancer	0.00042	0.00242	CcSEcCtD
Zafirlukast—Ill-defined disorder—Etoposide—testicular cancer	0.00042	0.00242	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000417	0.0024	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—testicular cancer	0.000415	0.00239	CcSEcCtD
Zafirlukast—Discomfort—Cisplatin—testicular cancer	0.000415	0.00239	CcSEcCtD
Zafirlukast—Vomiting—Vinblastine—testicular cancer	0.000412	0.00237	CcSEcCtD
Zafirlukast—Malaise—Etoposide—testicular cancer	0.000408	0.00235	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—testicular cancer	0.000408	0.00235	CcSEcCtD
Zafirlukast—Headache—Vinblastine—testicular cancer	0.000406	0.00234	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000403	0.00233	CcSEcCtD
Zafirlukast—Abdominal pain—Dactinomycin—testicular cancer	0.000403	0.00232	CcSEcCtD
Zafirlukast—Body temperature increased—Dactinomycin—testicular cancer	0.000403	0.00232	CcSEcCtD
Zafirlukast—Fatigue—Ifosfamide—testicular cancer	0.000403	0.00232	CcSEcCtD
Zafirlukast—Oedema—Cisplatin—testicular cancer	0.000403	0.00232	CcSEcCtD
Zafirlukast—Hypersensitivity—Bleomycin—testicular cancer	0.000403	0.00232	CcSEcCtD
Zafirlukast—Infection—Cisplatin—testicular cancer	0.0004	0.00231	CcSEcCtD
Zafirlukast—Pain—Ifosfamide—testicular cancer	0.0004	0.0023	CcSEcCtD
Zafirlukast—Thrombocytopenia—Cisplatin—testicular cancer	0.000394	0.00227	CcSEcCtD
Zafirlukast—Asthenia—Bleomycin—testicular cancer	0.000392	0.00226	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—testicular cancer	0.000389	0.00224	CcSEcCtD
Zafirlukast—Pruritus—Bleomycin—testicular cancer	0.000387	0.00223	CcSEcCtD
Zafirlukast—Feeling abnormal—Ifosfamide—testicular cancer	0.000385	0.00222	CcSEcCtD
Zafirlukast—Eosinophilia—Methotrexate—testicular cancer	0.000385	0.00222	CcSEcCtD
Zafirlukast—Nausea—Vinblastine—testicular cancer	0.000385	0.00222	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000382	0.0022	CcSEcCtD
Zafirlukast—Discomfort—Etoposide—testicular cancer	0.00038	0.00219	CcSEcCtD
Zafirlukast—Hypersensitivity—Dactinomycin—testicular cancer	0.000376	0.00217	CcSEcCtD
Zafirlukast—Abdominal discomfort—Methotrexate—testicular cancer	0.000373	0.00215	CcSEcCtD
Zafirlukast—Urticaria—Ifosfamide—testicular cancer	0.000371	0.00214	CcSEcCtD
Zafirlukast—Abdominal pain—Ifosfamide—testicular cancer	0.000369	0.00213	CcSEcCtD
Zafirlukast—Body temperature increased—Ifosfamide—testicular cancer	0.000369	0.00213	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000367	0.00212	CcSEcCtD
Zafirlukast—Infection—Etoposide—testicular cancer	0.000367	0.00211	CcSEcCtD
Zafirlukast—Asthenia—Dactinomycin—testicular cancer	0.000366	0.00211	CcSEcCtD
Zafirlukast—Neutropenia—Methotrexate—testicular cancer	0.000364	0.0021	CcSEcCtD
Zafirlukast—Thrombocytopenia—Etoposide—testicular cancer	0.000361	0.00208	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—testicular cancer	0.00036	0.00208	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—testicular cancer	0.00036	0.00207	CcSEcCtD
Zafirlukast—Diarrhoea—Dactinomycin—testicular cancer	0.000349	0.00201	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000348	0.00201	CcSEcCtD
Zafirlukast—Vomiting—Bleomycin—testicular cancer	0.000348	0.002	CcSEcCtD
Zafirlukast—Rash—Bleomycin—testicular cancer	0.000345	0.00199	CcSEcCtD
Zafirlukast—Pain—Cisplatin—testicular cancer	0.000345	0.00199	CcSEcCtD
Zafirlukast—Dermatitis—Bleomycin—testicular cancer	0.000344	0.00199	CcSEcCtD
Zafirlukast—Hypersensitivity—Ifosfamide—testicular cancer	0.000344	0.00199	CcSEcCtD
Zafirlukast—Neutropenia—Epirubicin—testicular cancer	0.00034	0.00196	CcSEcCtD
Zafirlukast—Asthenia—Ifosfamide—testicular cancer	0.000335	0.00193	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—testicular cancer	0.000333	0.00192	CcSEcCtD
Zafirlukast—Feeling abnormal—Cisplatin—testicular cancer	0.000332	0.00191	CcSEcCtD
Zafirlukast—Pruritus—Ifosfamide—testicular cancer	0.000331	0.00191	CcSEcCtD
Zafirlukast—Nausea—Bleomycin—testicular cancer	0.000325	0.00187	CcSEcCtD
Zafirlukast—Vomiting—Dactinomycin—testicular cancer	0.000324	0.00187	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—testicular cancer	0.000323	0.00187	CcSEcCtD
Zafirlukast—Rash—Dactinomycin—testicular cancer	0.000322	0.00185	CcSEcCtD
Zafirlukast—Diarrhoea—Ifosfamide—testicular cancer	0.00032	0.00184	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Etoposide—testicular cancer	0.000319	0.00184	CcSEcCtD
Zafirlukast—Body temperature increased—Cisplatin—testicular cancer	0.000318	0.00184	CcSEcCtD
Zafirlukast—Fatigue—Etoposide—testicular cancer	0.000318	0.00183	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—testicular cancer	0.000318	0.00183	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—testicular cancer	0.000316	0.00182	CcSEcCtD
Zafirlukast—Pain—Etoposide—testicular cancer	0.000316	0.00182	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—testicular cancer	0.000315	0.00182	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—testicular cancer	0.000313	0.0018	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—testicular cancer	0.000311	0.00179	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—testicular cancer	0.000311	0.00179	CcSEcCtD
Zafirlukast—Dizziness—Ifosfamide—testicular cancer	0.000309	0.00178	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—testicular cancer	0.000304	0.00175	CcSEcCtD
Zafirlukast—Feeling abnormal—Etoposide—testicular cancer	0.000304	0.00175	CcSEcCtD
Zafirlukast—Nausea—Dactinomycin—testicular cancer	0.000303	0.00175	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—testicular cancer	0.000303	0.00175	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Etoposide—testicular cancer	0.000302	0.00174	CcSEcCtD
Zafirlukast—Vomiting—Ifosfamide—testicular cancer	0.000297	0.00171	CcSEcCtD
Zafirlukast—Hypersensitivity—Cisplatin—testicular cancer	0.000297	0.00171	CcSEcCtD
Zafirlukast—Rash—Ifosfamide—testicular cancer	0.000295	0.0017	CcSEcCtD
Zafirlukast—Dermatitis—Ifosfamide—testicular cancer	0.000294	0.0017	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000294	0.0017	CcSEcCtD
Zafirlukast—Urticaria—Etoposide—testicular cancer	0.000293	0.00169	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—testicular cancer	0.000293	0.00169	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—testicular cancer	0.000293	0.00169	CcSEcCtD
Zafirlukast—Abdominal pain—Etoposide—testicular cancer	0.000292	0.00168	CcSEcCtD
Zafirlukast—Body temperature increased—Etoposide—testicular cancer	0.000292	0.00168	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—testicular cancer	0.000291	0.00168	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—testicular cancer	0.000291	0.00168	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—testicular cancer	0.00029	0.00167	CcSEcCtD
Zafirlukast—Asthenia—Cisplatin—testicular cancer	0.000289	0.00167	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—testicular cancer	0.000282	0.00162	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—testicular cancer	0.00028	0.00162	CcSEcCtD
Zafirlukast—Nausea—Ifosfamide—testicular cancer	0.000278	0.0016	CcSEcCtD
Zafirlukast—Diarrhoea—Cisplatin—testicular cancer	0.000276	0.00159	CcSEcCtD
Zafirlukast—Hypersensitivity—Etoposide—testicular cancer	0.000272	0.00157	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—testicular cancer	0.000271	0.00156	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—testicular cancer	0.000269	0.00155	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—testicular cancer	0.000269	0.00155	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—testicular cancer	0.000268	0.00155	CcSEcCtD
Zafirlukast—Asthenia—Etoposide—testicular cancer	0.000265	0.00153	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—testicular cancer	0.000262	0.00151	CcSEcCtD
Zafirlukast—Pruritus—Etoposide—testicular cancer	0.000261	0.00151	CcSEcCtD
Zafirlukast—Vomiting—Cisplatin—testicular cancer	0.000256	0.00148	CcSEcCtD
Zafirlukast—Rash—Cisplatin—testicular cancer	0.000254	0.00146	CcSEcCtD
Zafirlukast—Dermatitis—Cisplatin—testicular cancer	0.000254	0.00146	CcSEcCtD
Zafirlukast—Diarrhoea—Etoposide—testicular cancer	0.000253	0.00146	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—testicular cancer	0.000251	0.00145	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—testicular cancer	0.000245	0.00141	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—testicular cancer	0.000244	0.00141	CcSEcCtD
Zafirlukast—Dizziness—Etoposide—testicular cancer	0.000244	0.00141	CcSEcCtD
Zafirlukast—Nausea—Cisplatin—testicular cancer	0.000239	0.00138	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—testicular cancer	0.000235	0.00136	CcSEcCtD
Zafirlukast—Vomiting—Etoposide—testicular cancer	0.000235	0.00135	CcSEcCtD
Zafirlukast—Rash—Etoposide—testicular cancer	0.000233	0.00134	CcSEcCtD
Zafirlukast—Dermatitis—Etoposide—testicular cancer	0.000233	0.00134	CcSEcCtD
Zafirlukast—Headache—Etoposide—testicular cancer	0.000231	0.00133	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—testicular cancer	0.000231	0.00133	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—testicular cancer	0.000231	0.00133	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—testicular cancer	0.000229	0.00132	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—testicular cancer	0.000228	0.00131	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—testicular cancer	0.000227	0.00131	CcSEcCtD
Zafirlukast—Infection—Methotrexate—testicular cancer	0.00022	0.00127	CcSEcCtD
Zafirlukast—Nausea—Etoposide—testicular cancer	0.000219	0.00126	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—testicular cancer	0.000218	0.00125	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—testicular cancer	0.000216	0.00125	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—testicular cancer	0.000216	0.00124	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—testicular cancer	0.000216	0.00124	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—testicular cancer	0.000213	0.00123	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—testicular cancer	0.000212	0.00122	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—testicular cancer	0.000207	0.00119	CcSEcCtD
Zafirlukast—Infection—Epirubicin—testicular cancer	0.000206	0.00119	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—testicular cancer	0.000203	0.00117	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000201	0.00116	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—testicular cancer	0.0002	0.00115	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—testicular cancer	0.0002	0.00115	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—testicular cancer	0.0002	0.00115	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—testicular cancer	0.000197	0.00114	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—testicular cancer	0.000195	0.00112	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—testicular cancer	0.000191	0.0011	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000191	0.0011	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—testicular cancer	0.000191	0.0011	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—testicular cancer	0.00019	0.0011	CcSEcCtD
Zafirlukast—Pain—Methotrexate—testicular cancer	0.000189	0.00109	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000188	0.00109	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—testicular cancer	0.000187	0.00108	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—testicular cancer	0.000187	0.00108	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—testicular cancer	0.000182	0.00105	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—testicular cancer	0.000182	0.00105	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—testicular cancer	0.000181	0.00104	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000179	0.00103	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—testicular cancer	0.000178	0.00103	CcSEcCtD
Zafirlukast—Pain—Epirubicin—testicular cancer	0.000177	0.00102	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—testicular cancer	0.000176	0.00101	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—testicular cancer	0.000175	0.00101	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—testicular cancer	0.000175	0.00101	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000174	0.00101	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—testicular cancer	0.000173	0.000998	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—testicular cancer	0.00017	0.000983	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—testicular cancer	0.000169	0.000976	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—testicular cancer	0.000169	0.000972	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000165	0.000953	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—testicular cancer	0.000165	0.000952	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—testicular cancer	0.000164	0.000948	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—testicular cancer	0.000164	0.000944	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—testicular cancer	0.000164	0.000943	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—testicular cancer	0.000164	0.000943	CcSEcCtD
Zafirlukast—Hypersensitivity—Methotrexate—testicular cancer	0.000163	0.000939	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—testicular cancer	0.000159	0.000915	CcSEcCtD
Zafirlukast—Feeling abnormal—Doxorubicin—testicular cancer	0.000158	0.00091	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000157	0.000903	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—testicular cancer	0.000156	0.000902	CcSEcCtD
Zafirlukast—Hypersensitivity—Epirubicin—testicular cancer	0.000152	0.000879	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—testicular cancer	0.000152	0.000877	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—testicular cancer	0.000151	0.000873	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—testicular cancer	0.000151	0.000873	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—testicular cancer	0.000151	0.000872	CcSEcCtD
Zafirlukast—Asthenia—Epirubicin—testicular cancer	0.000148	0.000856	CcSEcCtD
Zafirlukast—Pruritus—Epirubicin—testicular cancer	0.000146	0.000844	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—testicular cancer	0.000146	0.000843	CcSEcCtD
Zafirlukast—Diarrhoea—Epirubicin—testicular cancer	0.000142	0.000816	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—testicular cancer	0.000141	0.000813	CcSEcCtD
Zafirlukast—Vomiting—Methotrexate—testicular cancer	0.000141	0.000811	CcSEcCtD
Zafirlukast—Rash—Methotrexate—testicular cancer	0.000139	0.000804	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—testicular cancer	0.000139	0.000803	CcSEcCtD
Zafirlukast—Headache—Methotrexate—testicular cancer	0.000138	0.000799	CcSEcCtD
Zafirlukast—Asthenia—Doxorubicin—testicular cancer	0.000137	0.000792	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—testicular cancer	0.000137	0.000789	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—testicular cancer	0.000135	0.000781	CcSEcCtD
Zafirlukast—Vomiting—Epirubicin—testicular cancer	0.000132	0.000759	CcSEcCtD
Zafirlukast—Nausea—Methotrexate—testicular cancer	0.000131	0.000757	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—testicular cancer	0.000131	0.000755	CcSEcCtD
Zafirlukast—Rash—Epirubicin—testicular cancer	0.00013	0.000752	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—testicular cancer	0.00013	0.000752	CcSEcCtD
Zafirlukast—Headache—Epirubicin—testicular cancer	0.00013	0.000747	CcSEcCtD
Zafirlukast—Dizziness—Doxorubicin—testicular cancer	0.000127	0.00073	CcSEcCtD
Zafirlukast—Nausea—Epirubicin—testicular cancer	0.000123	0.000709	CcSEcCtD
Zafirlukast—Vomiting—Doxorubicin—testicular cancer	0.000122	0.000702	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—testicular cancer	0.000121	0.000696	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—testicular cancer	0.000121	0.000695	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—testicular cancer	0.00012	0.000692	CcSEcCtD
Zafirlukast—Nausea—Doxorubicin—testicular cancer	0.000114	0.000656	CcSEcCtD
